A phase II Randomized Double blind Placebo controlled Single dose Dose ranging Study of the Efficacy and Safety of MEDI4893 a Human Monoclonal Antibody Against Staphylococcus aureus Alpha Toxin in Mechanically Ventilated Adult Subjects